A Longitudinal Study of Sars-CoV-2 Antibody Seroprevalence and Mitigation Behaviors among College Students at an Arkansas University

Saved in:
Bibliographic Details
Title: A Longitudinal Study of Sars-CoV-2 Antibody Seroprevalence and Mitigation Behaviors among College Students at an Arkansas University
Language: English
Authors: Jaimi L. Allen, Benjamin C. Amick III, Mark L. Williams, Joshua L. Kennedy, Karl W. Boehme, J. Craig Forrest, Brian Primack, Erica Ashley Sides, Wendy N. Nembhard, Stephanie F. Gardner, Jessica N. Snowden, Laura P. James, Ericka Olgaard, Jay Gandy (ORCID 0000-0001-8792-8079)
Source: Journal of American College Health. 2025 73(1):331-340.
Availability: Taylor & Francis. Available from: Taylor & Francis, Ltd. 530 Walnut Street Suite 850, Philadelphia, PA 19106. Tel: 800-354-1420; Tel: 215-625-8900; Fax: 215-207-0050; Web site: http://www.tandf.co.uk/journals
Peer Reviewed: Y
Page Count: 10
Publication Date: 2025
Sponsoring Agency: National Center for Advancing Translational Sciences (NCATS) (DHHS/NIH)
Contract Number: UL1TR3107
Document Type: Journal Articles
Reports - Research
Education Level: Higher Education
Postsecondary Education
Descriptors: College Students, COVID-19, Pandemics, Health Behavior, Student Behavior, Immunization Programs, Physiology, Student Characteristics, Health, Information Sources, Symptoms (Individual Disorders)
Geographic Terms: Arkansas
DOI: 10.1080/07448481.2023.2217456
ISSN: 0744-8481
1940-3208
Abstract: Objective: Assess university students' SARS-CoV-2 antibody seroprevalence and mitigation behaviors over time. Participants: Randomly selected college students (N = 344) in a predominantly rural Southern state. Methods: Participants provided blood samples and completed self-administered questionnaires at three timepoints over the academic year. Adjusted odds ratios and 95% confidence intervals were estimated from logistic regression analyses. Results: SARS-CoV-2 antibody seroprevalence was 18.2% in September 2020, 13.1% in December, and 45.5% in March 2021 (21% for those with no vaccination history). SARS-CoV-2 antibody seroprevalence was associated with large social gatherings, staying local during the summer break, symptoms of fatigue or rhinitis, Greek affiliation, attending Greek events, employment, and using social media as the primary COVID-19 information source. In March 2021, seroprevalence was associated with receiving at least one dose of a COVID-19 vaccination. Conclusion: SARS-CoV-2 seroprevalence was higher in this population of college students than previous studies. Results can assist leaders in making informed decisions as new variants threaten college campuses.
Abstractor: As Provided
Entry Date: 2025
Accession Number: EJ1456937
Database: ERIC
Full text is not displayed to guests.
Description
Abstract:Objective: Assess university students' SARS-CoV-2 antibody seroprevalence and mitigation behaviors over time. Participants: Randomly selected college students (N = 344) in a predominantly rural Southern state. Methods: Participants provided blood samples and completed self-administered questionnaires at three timepoints over the academic year. Adjusted odds ratios and 95% confidence intervals were estimated from logistic regression analyses. Results: SARS-CoV-2 antibody seroprevalence was 18.2% in September 2020, 13.1% in December, and 45.5% in March 2021 (21% for those with no vaccination history). SARS-CoV-2 antibody seroprevalence was associated with large social gatherings, staying local during the summer break, symptoms of fatigue or rhinitis, Greek affiliation, attending Greek events, employment, and using social media as the primary COVID-19 information source. In March 2021, seroprevalence was associated with receiving at least one dose of a COVID-19 vaccination. Conclusion: SARS-CoV-2 seroprevalence was higher in this population of college students than previous studies. Results can assist leaders in making informed decisions as new variants threaten college campuses.
ISSN:0744-8481
1940-3208
DOI:10.1080/07448481.2023.2217456